Pradier, Melanie F.
Reis, Bernhard
Jukofsky, Lori
Milletti, Francesca
Ohtomo, Toshihiko
Perez-Cruz, Fernando
Puig, Oscar
Funding for this research was provided by:
ADVENTURE (TEC2015-69868-C2-1-R)
MLPM2012 (316861)
Comunidad de Madrid (S2013/ICE-2845)
Harvard Data Science Initiative
Center for Research on Computation and Society, Harvard University
Article History
Received: 20 November 2018
Accepted: 14 March 2019
First Online: 28 March 2019
Ethics approval and consent to participate
: The study was approved by institutional review boards of participating centers and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. NCT01507168 trial was approved by the institutional IRBs from all participating centers, and all patients received informed consent; consent from study participants was written; it has already been published with a previous study in []. Our study adheres to CONSORT guidelines for reporting clinical trials. A full list of all ethics commitees, participant centers, and additional details regarding this trial can be retrieved at:.
: Not applicable.
: Roche employment and stock for authors BR, LJ, FM, and OP. Author TO was employed by Chugai.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.